Jyothy laboratories has announced a conference call for analysts and investors to discuss its Q3FY26 financial performance. The call is scheduled for Monday, February 9, 2026 at 16:00 hours IST, following the declaration of unaudited financial results for the quarter and nine months ended December 31, 2025.

Regulatory Compliance and Announcement Details

The company made this announcement on February 2, 2026, pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was sent to both BSE Limited and National Stock Exchange of India Limited, with the company trading under BSE Code 532926 and NSE Scrip Code JYOTHYLAB.

Shreyas Trivedi, Head – Legal & Company Secretary, signed the official communication digitally on February 2, 2026 at 16:44:29 +05'30'. The company has also made this information available on its official website at www.jyothylabs.com .

Conference Call Access Information

ICICI Securities is coordinating the Q3FY26 results conference call, providing comprehensive access options for participants:

Key Coordinators and Contact Information

The conference call will be managed by senior executives from ICICI Securities:

• Mr. Jaideep Goswami, Head of Equities serves as the primary call coordinator
• Mr. Manoj Menon, Head of Research is available at +91 22 6807 7209
• Mr. Dhiraj Mistry can be reached at +91 22 6807 7649
• Mr. Rushad Kapadia handles clarifications at +91 22 6807 7334

Company Information

Jyothy Labs Limited operates under CIN L24240MH1992PLC128651 and is headquartered at 'Ujala House', Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059. The company maintains its corporate communications through official channels including phone +91 022-6689 2800 and website www.jyothylabs.com .

The conference call will provide insights into the company's financial performance for the quarter ended December 31, 2025, and discuss the strategic direction forward. Participants can access detailed connection information and register through the Diamond Pass registration link provided by ICICI Securities.

In a significant move within the promoter group of Jyothy Laboratories , a substantial number of equity shares have been transferred to family trusts. This internal reorganization, while large in scale, maintains the overall shareholding structure of the company.

Key Details of the Share Transfer

Impact on Shareholding Structure

• Total Shares Transferred: 78.5 crore
• Promoter Group Holdings: Remains unchanged at 62.89%
• Overall Shareholding Structure: No change reported

Significance of the Transaction

This share transfer represents an internal reorganization within the promoter group of Jyothy Laboratories. Such moves are often undertaken for various reasons, including estate planning, wealth management, or streamlining of family holdings.

It's important to note that despite the large number of shares involved, there is no change in the overall promoter group holdings or the company's total shareholding structure. This indicates that the transfer is purely an internal arrangement and does not affect the control or management of the company.

Investors and market watchers may view this development as a neutral event, as it does not alter the fundamental ownership structure of Jyothy Laboratories. However, it does provide insight into the promoter group's approach to managing their significant stake in the company.

Shareholders and potential investors should keep an eye on any further announcements or disclosures from the company regarding changes in shareholding patterns or management structure.